Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
Obbina Abani(Unknown), Carol Adams, Mahmoud Abouibrahim, Sadia Abbasi, Amaka Achara, Ahmed Abou-Haggar, Abeer Ul Amna Abeer Ul Amna, Janet Acheson(University of Dundee), Althaf Abdul Rasheed, Jacqueline Adabie-Ankrah, Yazeed Abed El Khaleq, Judith Abrams, Alfie Abbott, Matthew Adam, Basir Abdul, Nabeel Abdallah, Abraheem Abraheem, Rasheed Abdul-Raheem, Mustafa Abbas, Niyaz Abdulshukkoor, Kula Abdusamad, Akata Abung, Catherine Acton, Amina Abdulle, Bushra Abdelqader, Yaa Aceampong, Miriam Abraham, Hani Abo-Leyah(University of Dundee), Huzaifa Adamali, Syed M Abubacker, Ashraf Omar Abdelaziz(Ain Shams University), Sara J. Adair, Andrés Acosta(Mayo Clinic), Adebanke Aboaba, Ahmad Abu-Arafeh, Fatima Abbas, Katrina Abernethy, Mohamed A. O. Abdelfattah, Abdulfatahi Abdulmumeen, Hyacinth-John Abu(University of Dundee), Rezan A. Kadir(The Royal Free Hospital), Ali Abbas(University of Dundee), Fiona Adam, Devikumar Acharya, Hakam Abbass, Abdulakeem Ajibode, Tizzy Abraham, Mai Abedalla
Cited by 521
Related Papers
Endoscopic sleeve gastroplasty for treatment of class 1 and 2 obesity (MERIT): a prospective, multicentre, randomised trial
|The Lancet|2022|311
Endoscopic Sleeve Gastroplasty for Obesity: a Multicenter Study of 248 Patients with 24 Months Follow-Up
|Obesity Surgery|2017|231
Effect of Convalescent Plasma on Organ Support–Free Days in Critically Ill Patients With COVID-19
|JAMA|2021|212
Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study
|The Lancet Respiratory Medicine|2022|211
Targeted CRISPR screening identifies PRMT5 as synthetic lethality combinatorial target with gemcitabine in pancreatic cancer cells
|Proceedings of the National Academy of Sciences|2020|113